Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Johnson & Johnson Janssen pharmaceutical business in the Pharma 50

Janssen (Johnson & Johnson’s pharmaceutical segment)

Rank: 4

2022 Rank: 4

New Brunswick, New Jersey (Janssen HQ in Titusville, New Jersey), United States
www.janssen.com

2022 Revenues ($USD) : $52,563,000,000.00
2022 R&D spend : $11,622,000,000.00
2022 Number of Employees : not available
Fiscal Year End : 01/02/23
Leader : Jennifer Taubert, EVP and worldwide chair of pharmaceuticals at Johnson & Johnson

Johnson & Johnson's pharma division saw slow and steady growth in 2022. The biologics Stelara and Tremfya continued to gain market share. Loss of exclusivity, however, pressured sales of the immunosuppressive drug Remicade. Additionally, Zytiga faced similar issues in the European Union. Imbruvica sales were also sluggish due to global pressures and a lagging market for chronic lymphocytic leukemia therapies. In the positive column, the oncology drugs Darzalex and Erleada saw strong sales, helping support the company's goal of achieving $60 billion in pharma sales by 2025. Johnson & Johnson plans to sharpen its focus on drug development and medical devices by spinning off its consumer health business by November 2023. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE